EUVIMEDScopri EUVIMED
QuerschnittstudieOpen access

Patients’ Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study

Marco Santos Teles iD, Karolina Bryl iD, Susan Chimonas iD, Atif Khan iD, Andrew S Epstein iD, Bobby Daly iD, Han Xiao iD, Jun J Mao iD

JMIR Cancer · 2026-02-04 · 12 · e81346-e81346

DOI: 10.2196/81346 ↗

At a glance

Querschnittstudie in JMIR Cancer, published online on 2026-02-04. Written by Marco Santos Teles and 7 co-authors. Institution: Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 205 East 64th Street, New York, NY, 10022, United States, 1 646 608 8552. Major MEDLINE topics: Artificial Intelligence, Neoplasms, Health Knowledge, Attitudes, Practice. Cited 4 times so far (Crossref); 17 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Artificial intelligence (AI) is being rapidly integrated into oncologic care, yet little is known about how patients perceive these applications. Understanding patient perceptions is critical to ensuring AI applications align with their needs and preferences.

Objective

This study aimed to evaluate oncology patients’ attitudes and beliefs on the use of AI across clinical touchpoints in cancer care.

Methods

We conducted a cross-sectional survey study with adult oncology patients from September to December 2024. The survey assessed patients’ comfort with AI use across 8 clinical touchpoints of cancer care (eg, screening, diagnosis, treatment) on a 5-point Likert scale (1=very uncomfortable to 5=very comfortable). Patients also rated their concerns about AI, including potential harms related to its use (eg, medical errors, privacy breaches), on a 3-point Likert scale (1=not concerned to 3=very concerned).

Results

Of 383 patients approached, 330 (86.2% response rate) participated; 184 (55.9%) were male, 162 (49.4%) were aged 65 years or older, 35 (10.8%) were Black, 40 (12.1%) were Hispanic or Latino, and 233 (72.6%) were actively receiving cancer treatment. Patients were most comfortable with AI use in cancer screening (80.2%) and supportive care applications, including exercise (78.2%), diet (74.8%), and herbs/supplements (72.4%). Patients were least comfortable with AI use to assist with diagnosis (70.4%), symptom management (67.5%), treatment planning (64.8%), and prognosis (61.5%). Nonetheless, about half (49.7%) were at least somewhat concerned with the use of AI in cancer care, most commonly about the loss of human interaction and medical errors.

Conclusions

Although the majority of oncology patients had a favorable view of AI in cancer care, nearly half had concerns about potential harms. Incorporating patient perspectives into AI development is essential for patient-centered and high-quality cancer care.

Subjects

MeSH terms (MEDLINE)

Artificial IntelligenceNeoplasmsHealth Knowledge, Attitudes, PracticeHumansCross-Sectional StudiesMaleFemaleMiddle AgedAgedSurveys and QuestionnairesAdult

Author keywords

artificial intelligencecancer caredigital healthpatient attitudespatient perspectives

Authors and institutions

  • Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 205 East 64th Street, New York, NY, 10022, United States, 1 646 608 8552.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

ORCID profiles: Marco Santos Teles, Karolina Bryl, Susan Chimonas, Atif Khan, Andrew S Epstein, Bobby Daly, Han Xiao, Jun J Mao

Funding

  • NCI NIH HHS

Cite

APA

Santos Teles, M., Bryl, K., Chimonas, S., Khan, A., Epstein, A. S., Daly, B., Xiao, H., & Mao, J. J. (2026). Patients’ Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study. JMIR Cancer, 12, e81346-e81346. https://doi.org/10.2196/81346

Vancouver

Santos Teles M, Bryl K, Chimonas S, Khan A, Epstein AS, Daly B, et al. Patients’ Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study. JMIR Cancer. 2026;12:e81346-e81346. doi:10.2196/81346

BibTeX
@article{SantosTeles2026,
  author = {Santos Teles, Marco and Bryl, Karolina and Chimonas, Susan and Khan, Atif and Epstein, Andrew S and Daly, Bobby and Xiao, Han and Mao, Jun J},
  title = {Patients’ Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study},
  journal = {JMIR Cancer},
  year = {2026},
  volume = {12},
  pages = {e81346--e81346},
  doi = {10.2196/81346}
}
Start for free →